Z-0120-2022 Class II Terminated
FDA device recall Z-0120-2022 was initiated by Ortho Clinical Diagnostics Inc on Sep 10, 2021 and is designated Class II. Reason for recall: VITROS Immunodiagnostic Products Anti-SARS-CoV-2 IgG Quantitative Controls Outside of Expected Control Range, potential for delayed results The recall status is terminated (terminated Feb 13, 2024). Affected quantity: US: 64 OUS: 200.
Recall details
- Product Type
- Devices
- Report Date
- Oct 27, 2021
- Initiation Date
- Sep 10, 2021
- Termination Date
- Feb 13, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- US: 64 OUS: 200
Product description
Reason for recall
Distribution pattern
Worldwide Distribution: US (Nationwide) in states of: AL, AR, AZ, CA, CO, DC, FL, ID, KS, KY, LA, ME, MI, MS, MO, NY, TN, TX and WV; and OUS (Foreign) in countries of: Australia, Brazil, Canada, Chile, China, Colombia, India, Japan, Mexico, Singapore, United Kingdom, France, Germany, Italy, Spain, Portugal, Russia, Denmark, Norway, Sweden, Belgium, and The Netherlands.
Code information
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0120-2022
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026